Commentaries and Viewpoints

Benchmarking biology research organizations using a new, dedicated tool
W. van Harten, L. van Bokhorst and H. van Luenen
Volume 2, Issue 1, June 2008

Epigenetics and cancer, 2nd IARC meeting, Lyon, France, 6 and 7 December 2007
MP. Lambert and Z. Herceg
Volume 2, Issue 1, June 2008

The MINDACT trial: The first prospective clinical validation of a genomic tool
F. Cardoso, M. Piccart-Gebhart, L. Van't Veer and on behalf of the TRANSBIG consortium Emiel Rutgers
Volume 1, Issue 3, December 2007

Barriers to translation of research
F. Gannon
Volume 1, Issue 3, December 2007

Europe combating cancer: The European Union's commitment to cancer research in the 6th Framework Programme
S. Jungbluth, O. Kelm, JW. van de Loo, E. Manoussaki, M. Vidal, M. Hallen and O. Trias
Volume 1, Issue 1, June 2007

News

From January 1, 2017 Molecular Oncology is published by FEBS Press and Wiley

Molecular Oncology has become fully Open Access, allowing everyone to read the journal irrespective of speciality, host institution or location. All articles are published under the Creative Commons Attribution License (CC BY) to meet funders’ requirements worldwide.

 

Citation Metrics

  • 2016 2-Year Impact Factor: 5.314
  • 2016 5-Year Impact Factor: 5.957
  • 2016 CiteScore: 5.25

Editorial Board

Editor-in-Chief Julio Celis

Senior Associate Editors Anne-Lise Børresen-Dale and  Ulrik Ringborg 

Managing Editor Jose Moreira

Future Events in Oncology

06 - 09 September, 2017, Mainz/Frankfurt, Germany
08 - 12 September, 2017, Madrid, Spain
05 - 06 October, 2017, Buenos Aires, Argentina
13 - 14 October, 2017, Zürich, Switzerland
24 - 27 November, 2017, Milan, Italy
02 - 05 December, 2017, Florida, USA
05 - 09 December, 2017, Texas, USA